Tianjin Ringpu Bio-Technology Obtains New Veterinary Drug Registration Certificate

Stock News09-30

Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) announced that the company and its subsidiaries, including Tianjin Ringpu Bio-Technology Co.,Ltd. Kong Gang Economic Zone Branch, Ringpu (Baoding) Biological Pharmaceutical Co.,Ltd., and Guangzhou South China Agricultural University Biological Products Co.,Ltd., have recently obtained New Veterinary Drug Registration Certificates issued by the Ministry of Agriculture and Rural Affairs in accordance with the Veterinary Drug Administration Regulations and Veterinary Drug Registration Measures.

The new veterinary drug is named Newcastle Disease, Infectious Bronchitis, Avian Influenza (H9 subtype), Infectious Bursal Disease Quadrivalent Inactivated Vaccine (LaSota strain + RPVA0406 strain + TJ-4 strain + RPVA0706 strain).

The approval of this product fills the market gap for QX-type infectious bronchitis virus polyvalent vaccines in China, demonstrating the company's forward-looking strategic positioning and innovation capabilities in the poultry vaccine sector. This development enhances the company's poultry vaccine product portfolio, helps further consolidate its leading position in the poultry vaccine field, and is expected to generate new performance growth drivers for the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197975194?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 16:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197975194","market":"sg","top_or_hot":-1,"title":"Tianjin Ringpu Bio-Technology Obtains New Veterinary Drug Registration Certificate","media":"Stock News","content":"<p>Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) announced that the company and its subsidiaries, including Tianjin Ringpu Bio-Technology Co.,Ltd. Kong Gang Economic Zone Branch, Ringpu (Baoding) Biological Pharmaceutical Co.,Ltd., and Guangzhou South China Agricultural University Biological Products Co.,Ltd., have recently obtained New Veterinary Drug Registration Certificates issued by the Ministry of Agriculture and Rural Affairs in accordance with the Veterinary Drug Administration Regulations and Veterinary Drug Registration Measures.</p>\n<p>The new veterinary drug is named Newcastle Disease, Infectious Bronchitis, Avian Influenza (H9 subtype), Infectious Bursal Disease Quadrivalent Inactivated Vaccine (LaSota strain + RPVA0406 strain + TJ-4 strain + RPVA0706 strain).</p>\n<p>The approval of this product fills the market gap for QX-type infectious bronchitis virus polyvalent vaccines in China, demonstrating the company's forward-looking strategic positioning and innovation capabilities in the poultry vaccine sector. This development enhances the company's poultry vaccine product portfolio, helps further consolidate its leading position in the poultry vaccine field, and is expected to generate new performance growth drivers for the company.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Ringpu Bio-Technology Obtains New Veterinary Drug Registration Certificate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Ringpu Bio-Technology Obtains New Veterinary Drug Registration Certificate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-30 16:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) announced that the company and its subsidiaries, including Tianjin Ringpu Bio-Technology Co.,Ltd. Kong Gang Economic Zone Branch, Ringpu (Baoding) Biological Pharmaceutical Co.,Ltd., and Guangzhou South China Agricultural University Biological Products Co.,Ltd., have recently obtained New Veterinary Drug Registration Certificates issued by the Ministry of Agriculture and Rural Affairs in accordance with the Veterinary Drug Administration Regulations and Veterinary Drug Registration Measures.</p>\n<p>The new veterinary drug is named Newcastle Disease, Infectious Bronchitis, Avian Influenza (H9 subtype), Infectious Bursal Disease Quadrivalent Inactivated Vaccine (LaSota strain + RPVA0406 strain + TJ-4 strain + RPVA0706 strain).</p>\n<p>The approval of this product fills the market gap for QX-type infectious bronchitis virus polyvalent vaccines in China, demonstrating the company's forward-looking strategic positioning and innovation capabilities in the poultry vaccine sector. This development enhances the company's poultry vaccine product portfolio, helps further consolidate its leading position in the poultry vaccine field, and is expected to generate new performance growth drivers for the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0046","symbol_name":"生物疫苗","start_time":0,"source_url":"","article_id":"1197975194","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197975194","pubTimestamp":1759219562,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) announced that the company and its subsidiaries, including Tianjin Ringpu Bio-Technology Co.,Ltd. Kong Gang Economic Zone Branch, Ringpu (Baoding)...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300119":"瑞普生物","BK0046":"生物疫苗","BK0239":"医药制造","BK0070":"员工持股"},"translate_title":"天津环普生物获得新兽药注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300119":1},"content_text":"Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) announced that the company and its subsidiaries, including Tianjin Ringpu Bio-Technology Co.,Ltd. Kong Gang Economic Zone Branch, Ringpu (Baoding) Biological Pharmaceutical Co.,Ltd., and Guangzhou South China Agricultural University Biological Products Co.,Ltd., have recently obtained New Veterinary Drug Registration Certificates issued by the Ministry of Agriculture and Rural Affairs in accordance with the Veterinary Drug Administration Regulations and Veterinary Drug Registration Measures.\nThe new veterinary drug is named Newcastle Disease, Infectious Bronchitis, Avian Influenza (H9 subtype), Infectious Bursal Disease Quadrivalent Inactivated Vaccine (LaSota strain + RPVA0406 strain + TJ-4 strain + RPVA0706 strain).\nThe approval of this product fills the market gap for QX-type infectious bronchitis virus polyvalent vaccines in China, demonstrating the company's forward-looking strategic positioning and innovation capabilities in the poultry vaccine sector. This development enhances the company's poultry vaccine product portfolio, helps further consolidate its leading position in the poultry vaccine field, and is expected to generate new performance growth drivers for the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197975194","isCrawlerRequest":true}